We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: cancer
MedXY News
EnglishTag

cancer

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Optimizing Palliative Care for Effective Hospice Transitions in Cancer Patients: Insights from Multicenter Qualitative and Quantitative Evidence
Clinical Updatescancerhospice transitions

Optimizing Palliative Care for Effective Hospice Transitions in Cancer Patients: Insights from Multicenter Qualitative and Quantitative Evidence

By MedXY|Sep 15, 2026

This review synthesizes evidence identifying critical programmatic factors, relational dynamics, and interventions enhancing hospice transitions in cancer palliative care, emphasizing collaborative oncology-palliative care relationships and

Early Red Blood Cell Transfusion Strategy in Septic Shock Among Cancer Patients: Insights from the TRANSPORT Randomized Controlled Trial
Clinical Updates
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Red Blood Cell Transfusion
septic shock

Early Red Blood Cell Transfusion Strategy in Septic Shock Among Cancer Patients: Insights from the TRANSPORT Randomized Controlled Trial

By MedXY|Aug 27, 2026

The TRANSPORT trial showed no superiority of liberal versus restrictive RBC transfusion in septic shock patients with cancer, highlighting no mortality benefit and increased thrombotic events with liberal strategy, underscoring the need for

Cancer and Heart Failure in Scotland: Epidemiology, Interactions, and Prognostic Implications
Cardiologycancerepidemiology

Cancer and Heart Failure in Scotland: Epidemiology, Interactions, and Prognostic Implications

By MedXY|Jun 24, 2026

This review synthesizes evidence on the prevalence, incidence, and prognosis of cancer and heart failure comorbidity in Scotland, integrating recent cohort data and cardio-oncology research to inform clinical practice and future research di

Longitudinal Risk for Suicidal Self-Directed Violence Among Veterans With Cancer
newscancermental health

Longitudinal Risk for Suicidal Self-Directed Violence Among Veterans With Cancer

By MedXY|May 31, 2026

A national study of veterans with cancer found elevated suicide-related risk that persisted for years, especially among younger, unmarried, frail, or mentally ill patients and those with certain cancers such as central nervous system and th

Inflammatory and Cardiac Biomarkers Predict VTE and Bleeding Risks in Cancer Patients
Cardiologybiomarkersbleeding

Inflammatory and Cardiac Biomarkers Predict VTE and Bleeding Risks in Cancer Patients

By MedXY|Apr 22, 2026

Elevated levels of inflammatory and cardiac biomarkers are linked to higher risks of venous thromboembolism and bleeding in cancer patients, according to a post hoc analysis of the AVERT trial.

The Changing Landscape of Mortality in Diabetes: A Shift from Cardiovascular Dominance to Cancer and Dementia
CardiologycancerCardiovascular Mortality

The Changing Landscape of Mortality in Diabetes: A Shift from Cardiovascular Dominance to Cancer and Dementia

By MedXY|Mar 15, 2026

This review analyzes multinational data showing a significant decline in cardiovascular mortality among diabetes patients, alongside a concerning rise in dementia-related deaths and the emergence of cancer as a leading cause of mortality in

Medical Cannabis as an Opioid-Sparing Strategy: Evidence from Chronic and Cancer Pain Populations
Neurologycancercannabis

Medical Cannabis as an Opioid-Sparing Strategy: Evidence from Chronic and Cancer Pain Populations

By MedXY|Jan 1, 2026

This review synthesizes recent evidence from large-scale cohorts and synthetic control studies, demonstrating that medical cannabis participation and dispensary availability are significantly associated with reduced opioid prescriptions and

Acupuncture for Cancer-Related Insomnia: Limited, Low-Certainty Benefits Compared with Sham or No Treatment; Inferior to CBT‑I
Neurologyacupuncturecancer

Acupuncture for Cancer-Related Insomnia: Limited, Low-Certainty Benefits Compared with Sham or No Treatment; Inferior to CBT‑I

By MedXY|Dec 16, 2025

A 2025 Cochrane review (5 RCTs, 402 patients, mainly women with breast cancer) finds very low- to moderate-certainty evidence that acupuncture delivers small, uncertain sleep diary benefits versus sham or inactive controls and is probably l

Reduced Arsenic in Drinking Water Tied to Large Drops in Cancer and Cardiovascular Mortality
Cardiologycancercardiovascular disease

Reduced Arsenic in Drinking Water Tied to Large Drops in Cancer and Cardiovascular Mortality

By MedXY|Nov 17, 2025

A prospective cohort in Bangladesh found that declines in urinary arsenic were associated with substantially lower chronic-disease mortality—including cancer and cardiovascular deaths—supporting public-health efforts to reduce arsenic expos

Breaking the Immortality of Cancer Cells: Israel’s Groundbreaking RNA-Targeting Drug
Hematology-Oncologycancer

Breaking the Immortality of Cancer Cells: Israel’s Groundbreaking RNA-Targeting Drug

By MedXY|Nov 10, 2025

Israeli scientists have developed a novel small molecule drug that targets RNA structures maintaining cancer cell immortality, providing a promising new approach to treating hard-to-cure cancers with unparalleled precision.

What patients and clinicians want to know next: UK–Ireland research priorities for oesophageal and stomach cancers
Gastroenterologycancer

What patients and clinicians want to know next: UK–Ireland research priorities for oesophageal and stomach cancers

By MedXY|Nov 8, 2025

A UK–Ireland partnership ranked the top research uncertainties for oesophagogastric cancers; priorities emphasize personalising multimodal treatment, nutrition and quality of life, and stronger patient-centred trial design to accelerate mea

Impacts of Plant-Based Diets on Multimorbidity Risk in Cancer and Cardiometabolic Diseases Across Age Groups
Cardiologycancercardiometabolic diseases

Impacts of Plant-Based Diets on Multimorbidity Risk in Cancer and Cardiometabolic Diseases Across Age Groups

By MedXY|Oct 20, 2025

This analysis of EPIC and UK Biobank cohorts reveals that healthy plant-based diets reduce multimorbidity risk of cancer and cardiometabolic diseases, especially in middle-aged adults, underscoring diet’s role in chronic disease preve

Why Do Chimpanzees Rarely Get Cancer? Unveiling a Key Evolutionary Difference That Could Revolutionize Immunotherapy
Allergy & Immunologycancerimmunity

Why Do Chimpanzees Rarely Get Cancer? Unveiling a Key Evolutionary Difference That Could Revolutionize Immunotherapy

By MedXY|Oct 7, 2025

New research reveals that a protein called plasmin weakens human immune response against cancer compared to chimpanzees, offering promising strategies to enhance cancer immunotherapy.

Bridging the Gap: Addressing Inconsistent Reporting of Venous and Arterial Thrombotic Events in Cancer Clinical Trials
Clinical Updatescancerclinical trials

Bridging the Gap: Addressing Inconsistent Reporting of Venous and Arterial Thrombotic Events in Cancer Clinical Trials

By MedXY|Oct 6, 2025

Venous and arterial thrombotic events in cancer patients are underreported in clinical trials, impairing risk assessment and prevention strategies. Uniform and comprehensive reporting is imperative to improve patient outcomes and guide ther

The Hidden Risks of Alcohol: How Drinking Raises the Risk of 61 Diseases in Men—and Why Quitting Matters
Medical NewsAlcohol Consumptioncancer

The Hidden Risks of Alcohol: How Drinking Raises the Risk of 61 Diseases in Men—and Why Quitting Matters

By MedXY|Aug 26, 2025

Emerging research reveals that any alcohol consumption increases the risk of dozens of diseases, debunking myths about moderate drinking’s benefits—especially for Chinese men. Quitting alcohol triggers remarkable health improvements a

Extended Rivaroxaban Therapy in Cancer Patients with Low-Risk Pulmonary Embolism: 6 OR 18 Months？
Oncologycancerpulmonary embolism

Extended Rivaroxaban Therapy in Cancer Patients with Low-Risk Pulmonary Embolism: 6 OR 18 Months？

By MedXY|Oct 5, 2025

An 18-month course of rivaroxaban significantly lowers recurrent venous thromboembolism compared to 6 months in cancer patients with low-risk pulmonary embolism without a substantial increase in major bleeding risk.

Evaluating the Adjuvant Role of Low-Dose Aspirin in Cancer-Associated Venous Thromboembolism: Efficacy, Safety, and Clinical Implications
OncologyanticoagulationAspirin

Evaluating the Adjuvant Role of Low-Dose Aspirin in Cancer-Associated Venous Thromboembolism: Efficacy, Safety, and Clinical Implications

By MedXY|Oct 4, 2025

Low-dose aspirin added to anticoagulation for cancer-associated VTE reduces recurrence and PE-related mortality but increases bleeding risk, without improving overall survival or net clinical benefit over 6 months.

Emerging Roles of Circular RNAs in Cancer and Immunotherapy: Mechanisms and Clinical Potential
Allergy & Immunologycancerimmunotherapy

Emerging Roles of Circular RNAs in Cancer and Immunotherapy: Mechanisms and Clinical Potential

By MedXY|Oct 4, 2025

Circular RNAs (circRNAs) are pivotal regulators in cancer biology and immunotherapy, acting through mechanisms such as miRNA sponging, protein interactions, and translation. Their modulation of tumor immune microenvironment offers promising

Revolutionizing Cancer Therapy: Synergistic Action of Two Natural Bacteria in Complete Tumor Eradication
Clinical Updatescancer

Revolutionizing Cancer Therapy: Synergistic Action of Two Natural Bacteria in Complete Tumor Eradication

By MedXY|Oct 1, 2025

A novel bacteria-based therapy using two natural strains demonstrates complete tumor clearance in immunocompromised models, offering hope for cancer patients unsuitable for current immunotherapies.

Pickled Delights: Delicious but Potentially Dangerous?
Family Medicine & Nutritioncancerhealth risks

Pickled Delights: Delicious but Potentially Dangerous?

By MedXY|Oct 1, 2025

Explore the beloved tradition of pickled foods, their health impacts, and safer consumption tips.

1 / 2
12
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities